Sbi Securities Co., Ltd. Uro Gen Pharma Ltd. Transaction History
Sbi Securities Co., Ltd.
- $3.48 Trillion
- Q2 2025
A detailed history of Sbi Securities Co., Ltd. transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 78 shares of URGN stock, worth $1,497. This represents 0.0% of its overall portfolio holdings.
Number of Shares
78
Previous 67
16.42%
Holding current value
$1,497
Previous $741,000
44.26%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding URGN
# of Institutions
148Shares Held
44MCall Options Held
146KPut Options Held
42.1K-
Ubs Asset Management Americas Inc Chicago, IL4.36MShares$83.7 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY3.83MShares$73.6 Million0.69% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.21MShares$61.6 Million0.74% of portfolio
-
Menora Mivtachim Holdings Ltd.2.3MShares$44.2 Million0.17% of portfolio
-
Jefferies Financial Group Inc. New York, NY2.2MShares$42.2 Million0.27% of portfolio
About UroGen Pharma Ltd.
- Ticker URGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,740,500
- Market Cap $437M
- Description
- UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...